Chemo-Enzymatic Strategy for the Efficient Synthesis of Steroidal Drugs with 10α-Methyl Group and a Side Chain at C17-Position from Biorenewable Phytosterols
Open Access
- 29 March 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (4) , 1356-1364
Abstract
Steroidal pharmaceuticals with a 10α-methyl group or without the methyl group at C10-position are important medicines, but their synthesis is quite challenging, due to that the natural steroidal starting materials usually have a 10β-methyl group which is difficult to be inverted to 10α-methyl group. In this study, 3-((1R,3aS,4S,7aR)-1-((S)-1-hydroxypropan-2-yl)-7a-methyl-5-oxooctahydro-1H-inden-4-yl) propanoic acid (HIP-IPA, 2e) was demonstrated as a valuable intermediate for the synthesis of this kind of active pharmaceutical ingredients (APIs) with a side chain at C17-position. Knockout of a β-hydroxyacyl-CoA dehydrogenase gene and introduction of a sterol aldolase gene into the genetically modified strains of Mycobacterium fortuitum (ATCC 6841) resulted in strains N13Δhsd4AΩthl and N33Δhsd4AΩthl, respectively. Both strains transformed phytosterols into 2e. Compound 2e was produced in 62% isolated yield (25 g) using strain N13Δhsd4AΩthl, and further converted to (3S,3aS,9aS,9bS)-3-acetyl-3a,6-dimethyl-1,2,3,3a,4,5,8,9,9a,9b-decahydro-7H-cyclopenta[a]naphthalen-7-one, which is the key intermediate for the synthesis of dydrogesterone. This study not only overcomes a challenging synthetic problem by enabling an efficient synthesis of dydrogesterone-like steroidal APIs from phytosterols, the well-recognized cheap and readily available biobased raw materials, but also provides insights for redesigning the metabolic pathway of phytosterols to produce other new compounds of relevance to the steroidal pharmaceutical industry.Keywords
Funding Information
- National Key Research and Development Program of China (2019YFA0905300)
- National Natural Science Foundation of China (32171477)
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-KJGG-001, TSBICIP-PTJJ-007)
This publication has 31 references indexed in Scilit:
- Production of 21-hydroxy-20-methyl-pregna-1,4-dien-3-one by modifying multiple genes in MycolicibacteriumApplied Microbiology and Biotechnology, 2023
- A Dual Role Reductase from Phytosterols Catabolism Enables the Efficient Production of Valuable Steroid PrecursorsAngewandte Chemie International Edition, 2020
- New product identification in the sterol metabolism by an industrial strain Mycobacterium neoaurum NRRL B-3805Steroids, 2018
- A Distinct MaoC-like Enoyl-CoA Hydratase Architecture Mediates Cholesterol Catabolism in Mycobacterium tuberculosisACS Chemical Biology, 2014
- Mycobacterium tuberculosis Utilizes a Unique Heterotetrameric Structure for Dehydrogenation of the Cholesterol Side ChainBiochemistry, 2013
- Microbial steroid transformations: current state and prospectsApplied Microbiology and Biotechnology, 2012
- Cholesterol oxidase ChoD is not a critical enzyme accounting for oxidation of sterols to 3-keto-4-ene steroids in fast-growing Mycobacterium sp. VKM Ac-1815DThe Journal of Steroid Biochemistry and Molecular Biology, 2012
- Rv1106c from Mycobacterium tuberculosis Is a 3β-Hydroxysteroid DehydrogenaseBiochemistry, 2007
- Synthesis of labelled [13C6]testosterone and [13C5]19‐nortestosteroneJournal of Labelled Compounds and Radiopharmaceuticals, 1995
- Oxidative decarboxylation of 17(20)-dehydro-2,324-dinorcholanoic acidsTetrahedron Letters, 1990